Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,559 | 1,077 | -2,240 | -3,177 | -1,316 |
| Depreciation Amortization | 762 | 377 | 1,511 | 851 | 569 |
| Accounts receivable | 31 | -263 | -2,785 | -1,244 | -708 |
| Other Working Capital | -1,479 | -1,510 | -3,207 | -1,632 | 405 |
| Other Operating Activity | -165 | 1,126 | 4,928 | 4,613 | 775 |
| Operating Cash Flow | $2,708 | $807 | $-1,794 | $-588 | $-276 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | 37 | -35 | -3 | -3 |
| Investing Cash Flow | $-40 | $37 | $-35 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,014 | 1,014 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -95 |
| Common Stock Issued | 42 | N/A | 1,438 | 807 | 724 |
| Other Financing Activity | -489 | -202 | -749 | -618 | -368 |
| Financing Cash Flow | $566 | $811 | $690 | $189 | $261 |
| Beginning Cash Position | 1,537 | 1,537 | 2,676 | 2,676 | 2,676 |
| End Cash Position | 4,771 | 3,193 | 1,537 | 2,274 | 2,658 |
| Net Cash Flow | $3,234 | $1,656 | $-1,139 | $-402 | $-18 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,708 | 807 | -1,794 | -588 | -276 |
| Capital Expenditure | -95 | -14 | -35 | -3 | -3 |
| Free Cash Flow | 2,613 | 793 | -1,829 | -591 | -279 |